Stanhope agreed a joint venture partnership with Ontario Teachers' Pension Plan at the end of 2022 to purchase a 110,000 sq ft trio of properties within Cambridge Science Park. Established nearly 50 years ago, Cambridge Science Park is a globally renowned centre of excellence within the science and innovation Sector. The three-building campus at 194-198 Cambridge Science Park is set across 6.11 acres and is located in the ‘Cambridge Northern Cluster’. It is one of Europe’s most highly sought-after life science and technology campuses thanks to its unrivalled transport links, access to top talent from Cambridge University and thriving business ecosystem, with businesses ranging from spin-outs to multinationals. Working closely with the three existing tenants, Microsoft, Mundipharma (Napp Pharmaceutical) and CMR Surgical, the site also provides significant longer-term development opportunities.

In early 2023, Ontario Teachers' Pension Plan and Stanhope acquired a further property 163 Cambridge Science Park, which occupies a prominent location on the eastern side of the park and provides 10,197 sq ft of office space. It is currently occupied by speciality lighting company, Heraeus Noblelight Ltd and represents a near-term opportunity to develop prime life sciences lab space at the park.

The Cambridge deals build further on Ontario Teachers' Pension Plan and Stanhope PLC’s drive into prime life sciences campuses outside London, following a JV with Thomas White Oxford in March 2022 to deliver a £700m new global innovation district, Oxford North. Stanhope is also working with Ontario Teachers' Pension Plan at White City Place, London’s new creative and life sciences hub home to giants such as Novartis and Autolus, which Ontario Teachers' Pension Plan acquired in 2020.